v3.26.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common stock
Retained earnings
AOCI
Deferred Compensation, Share-Based Payments
Beginning balance (in shares) at Dec. 31, 2024   33,990,827      
Beginning balance at Dec. 31, 2024 $ 863,527 $ 531,674 $ 387,097 $ (55,244)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Restricted stock units vested (in shares)   195,444      
Restricted stock units vested 0        
Stock-based compensation expense 2,533       $ 2,533
Twelfth Stock Repurchase Plan, Common Stock, Repurchased Shares (in shares)   (233,077)      
Common stock repurchased (5,449) $ (5,449)      
Net income 26,126   26,126    
Other comprehensive loss, net of tax 18,055     18,055  
Cash dividends declared on common stock 16,580   16,580    
Ending balance (in shares) at Jun. 30, 2025   33,953,194      
Ending balance at Jun. 30, 2025 888,212 $ 528,758 396,643 (37,189)  
Beginning balance (in shares) at Mar. 31, 2025   34,105,516      
Beginning balance at Mar. 31, 2025 881,515 $ 532,124 392,737 (43,346)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Restricted stock units vested (in shares)   45,507      
Restricted stock units vested 0        
Stock-based compensation expense 1,245       1,245
Twelfth Stock Repurchase Plan, Common Stock, Repurchased Shares (in shares)   (197,829)      
Common stock repurchased (4,611) $ (4,611)      
Net income 12,215   12,215    
Other comprehensive loss, net of tax 6,157     6,157  
Cash dividends declared on common stock 8,309   8,309    
Ending balance (in shares) at Jun. 30, 2025   33,953,194      
Ending balance at Jun. 30, 2025 $ 888,212 $ 528,758 396,643 (37,189)  
Beginning balance (in shares) at Dec. 31, 2025 33,963,500 33,963,500      
Beginning balance at Dec. 31, 2025 $ 921,504 $ 531,100 421,619 (31,215)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Restricted stock units vested (in shares)   188,286      
Restricted stock units vested 0        
Stock-based compensation expense 2,865       2,865
Twelfth Stock Repurchase Plan, Common Stock, Repurchased Shares (in shares)   (413,264)      
Common stock repurchased (11,072) $ (11,072)      
Stock Issued During Period, Shares, Acquisitions   7,167,600      
Stock Issued During Period, Value, Acquisitions 184,996 $ 184,996      
Net income 36,493   36,493    
Other comprehensive loss, net of tax (6,781)     (6,781)  
Cash dividends declared on common stock $ 18,313   18,313    
Ending balance (in shares) at Jun. 30, 2026 40,906,122 40,906,122      
Ending balance at Jun. 30, 2026 $ 1,109,692 $ 707,889 439,799 (37,996)  
Beginning balance (in shares) at Mar. 31, 2026   41,249,873      
Beginning balance at Mar. 31, 2026 1,115,691 $ 716,432 432,255 (32,996)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Restricted stock units vested (in shares)   30,953      
Restricted stock units vested 0        
Stock-based compensation expense 1,569       $ 1,569
Twelfth Stock Repurchase Plan, Common Stock, Repurchased Shares (in shares)   (374,704)      
Common stock repurchased (10,112) $ (10,112)      
Net income 17,546   17,546    
Other comprehensive loss, net of tax (5,000)     (5,000)  
Cash dividends declared on common stock $ 10,002   10,002    
Ending balance (in shares) at Jun. 30, 2026 40,906,122 40,906,122      
Ending balance at Jun. 30, 2026 $ 1,109,692 $ 707,889 $ 439,799 $ (37,996)